Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* What are the long term effects of an IPV treatment evaluated with classical outcome parameters? (FEV1, Raw)
* Is the possible effect noticeable on the novel technique and is this comparable with the classical outcome parameters?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.
NCT02712190
Mechanically-assisted Ventilation in the Treatment of Moving Tumours With Photon and Proton Therapies
NCT03226925
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259
Safety Study of Non-invasive Ventilation Versus High-flow Oxygen in Patients With Hypoxemic Respiratory Failure Undergoing Fiberoptic Bronchoscopy.
NCT01870765
HERMES STUDY: Study on the Feasibility and Efficiency of Noninvasive Positive-Pressure Ventilation (NPPV) in Prehospital Care
NCT00375154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tests are taken before and after one week IPV treatment. IPV is applied for 1 week during the physical therapy treatment of chronic obstructive pulmonary desease (COPD) patients admitted to the hospital for an excarebation. The IPV treatment is an additional treatment upon the standard treatment of the patients. The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises. Patients are randomized into either the experimental group or the control group. The control group receives a standard physical therapy treatment without additional IPV treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intrapulmonary percussive ventilation
IPV is applied for 1 week (once a day) during the physical therapy treatment of the patient
intrapulmonary percussive ventilation
standard airwy claerance regime
The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises
standard treatment
breathing control exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intrapulmonary percussive ventilation
standard treatment
breathing control exercises
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to severe COPD
Exclusion Criteria
* Tracheotomise
* Pneumothorax
* Facial deformity
* Recent nose, mouth or ear operations
* Recent gastric operations.
* Intubated
* Epilepsy
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Artesis University College, Antwerp
OTHER
FLUIDDA nv
INDUSTRY
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wilfried De Backer
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wilfried De Backer, Phd
Role: PRINCIPAL_INVESTIGATOR
UZA pneumology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Antwerp
Edegem, Antwerp, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
artesis_G018
Identifier Type: OTHER
Identifier Source: secondary_id
PML_Kine_IPV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.